This research aims at evaluating prevalence and factors associated with metabolic syndrome (MS) in primary health care (PHC) nursing professionals. A multicenter, population-based and cross-sectional study was conducted in a team-tested sample of 1125 PHC nurses in the state of Bahia, Brazil. Sociodemographic, labor, lifestyle and human biology variables were investigated by mean of anamnesis. MS was evaluated according to the criteria of the first Brazilian Guideline for Metabolic Syndrome, which fully adopts the criteria of the National Cholesterol Education Program’s Adult Treatment Panel III. MS-associated factors were tested by using robust Poisson Regression. The prevalence of MS found was 24.4%; low High Density Lipoprotein (HDL) cholesterol was the most prevalent component of the syndrome. In the multivariate analysis, physical inactivity (PR = 1.25, 95% CI = 1.02–1.53), alcohol use (PR = 1.84, 95% CI = 1.22–2.77), acanthosis nigricans (PR = 3.23, 95% CI = 2.65–3.92), burnout syndrome (PR = 1.45, 95% CI = 1.17–1.81), (PR = 1.37, 95% CI = 1.12–1.69), working as a nursing technician (PR = 1.43, 95% CI = 1.14–1.80), were associated to MS. It was found that the prevalence of MS was high, which evidences the need for interventions in the PHC environment, improvement of working conditions, monitoring of worker safety and health, diet programs and physical activity.

The objective of the study was to evaluate the prevalence and factors associated with Burnout Syndrome (BS) in Primary Health Care (PHC) nursing professionals from the state of Bahia, Brazil. A multicentre, cross-sectional population-based study was conducted in a cluster sample among 1125 PHC Nursing professionals during the years 2017 and 2018. We used a questionnaire that included sociodemographic, labor and lifestyle variables and the Maslach Burnout Inventory scale to identify BS. The associations were evaluated using a robust Poisson regression with the hierarchical selection of the independent variables. The prevalence of BS was 18.3% and the associated factors were ethnicity (prevalence ratio (PR) = 0.62, confidence interval (CI) 95% = 0.47–0.83), residence (PR = 2.35, CI 95% = 1.79–3.09), economic situation (PR = 1.40, CI 95% = 1.06–1.86), satisfaction with current occupation (PR = 1.75, CI 95% = 1.31–2.33), (PR = 1.60, CI 95% = 1.23–2.08), rest (PR = 1.83, 95% CI = 1.41–2.37), technical resources and equipment (PR = 1.37, CI 95% = 1.06–1.77), night shift (PR = 1.49, CI 95% = 1.14–1.96), physical activity practice (PR = 1.72; CI 95% = 1.28–2.31), smoking (PR = 1.82, CI 95% = 1.35–2.45), and satisfaction with physical form (PR = 1.34, CI 95% = 1.01–179). Strategies are needed to prevent BS, with an emphasis on implementing worker health programs in the context of PHC.

Covid-19 is a respiratory infection caused by coronavirus-initially detected in China, in December 2019, which progresses to pneumonia in 81% of the cases, with an average fatality rate of 2.3% 1. It was declared a pandemic by the World Health Organization on March 11, 2020, almost ninety days after the first cases appeared. With high transmissibility, vertiginous increase in the number of cases, and clinical severity, it is impossible to disregard its psychological effects.

Effect of immunonutrition on serum levels of C-reactive protein and lymphocytes in patients with COVID-19: a randomized, controlled, double-blind clinical trial Efecto de la inmunonutrición sobre los niveles séricos de proteína Creactiva y linfocitos en pacientes con COVID-19: ensayo clínico doble ciego, controlado y aleatorio

Introduction: The SARS-CoV-2 related coronavirus has spread to almost every country, causing the COVID-19. The severity of COVID-19 is based on the inflammation caused by the cytokine storm. Inflammatory markers suggest a molecular explanation for the occurrence of severe disease and represent a possible treatment. Objective: This review aims to analyse the plausibility of using oral supplementation with immunonutrients. Discussion: Immunonutrition studies the interactions between nutrition, the immune system, infection, and inflammation of tissues. Arginine is a fundamental amino acid in processes of metabolic stress. Its deficiency implies in the capacity of immune response. ω-3 fatty acids demonstrated improved lung compliance, oxygenation, mechanical ventilation time and intensive care unit stay in patients with acute respiratory distress syndrome. Essential for cell-mediated immunity and T lymphocyte function, dietary nucleotides have been shown to improve the cytotoxicity of natural killer cells. Considering that the inversely proportional relationship between presence of IL-6 and TNF-α and the function of T cells is well established in patients with COVID-19, this reinforces the idea that the release control of these biomarkers can be a way to treat this disease. Conclusion: In this scenario, this review raises the possibility of using immunonutrition to improve immune response of individuals affected by COVID-19.

Background: Metabolic syndrome (MS) is associated with greater risk of morbimortality and it has high prevalence in people with mental illness. Objective: Estimate the prevalence of Metabolic Syndrome (MS) and its associated factors in the patients of a Psychosocial Care Center (CAPS in Brazilian Portuguese) in the city of Salvador, state of Bahia, Brazil. Method: Cross-sectional study set at CAPS in the city of Salvador-Bahia between August 2019 and February 2020. MS was evaluated according to the National Cholesterol Education Program’s Adult Treatment Panel III. In addition to descriptive statistics, gross and adjusted prevalence ratios were described. Results: MS was found in 100 (35.2%) individuals, 116 (40.9%) were obese and 165 (58.1%) had increased waist circumference. Polypharmacy was identified in 63 (22.3%) patients and 243 (85.9%) used antipsychotics. Under gross evaluation, women (PR = 1.88; 95%CI: 1.35–2.63) and those who used antidepressants (PR = 1.41; 95%CI: 1.05–1.88) showed an association with MS. After logistic regression, depression (PR = 1.86; 95%CI: 1.38–2.51), acanthosis (PR = 1.50; 95%CI: 1.18–1.90), use of antipsychotics (PR = 1.88; 95%CI: 1.13–2.75), and hypertriglyceridemic waist (PR = 3.33; 95%CI: 2.48–4.46) were associated with MS. Conclusion: The prevalence of MS signals multimorbidity among individuals with mental disorders and suggests a need for clinical screening.

Obesity is a chronic and multifactorial metabolic disease triggered by environmental, cultural, nutritional, genetic and psychosocial aspects, demand for clinical treatment performed by a multidisciplinary technical team. Ensuring care for patients with obesity, in the midst of the coronavirus pandemic, was fundamental for the surveillance and control of comorbidities and risk reduction in case of contamination. Health services that cared for obese individuals throughout the pandemic period needed to reinvent themselves to keep care in line with measures to combat coronavirus, reduce the risk of contamination and guarantee the necessary clinical support. The present work is a cross-sectional, qualitative, descriptive study, comprised of an experience report arising from the experience of health professionals during the treatment of obesity and its comorbidities, between March 2020 and December 2021. The report considered the observations and challenges in this atypical period of pandemic by the coronavirus. The activities took place in a closed inpatient unit (wards and apartments) of the Hospital da Obesidade, a reference for the care of patients with obesity, located in the city of Camaçari-BA. It is noteworthy that during the COVID-19 pandemic, the scenario of hospitalization for the treatment of morbid obesity was challenging because it was something new with continuous adaptations of care and work flows. During the entire period, the joint and humanized work of each professional was fundamental, who managed to act specifically in each different area, but who talk to each other. During the entire period of this work, even in the midst of so many adversities never experienced before, a daily construction of knowledge and actions was carried out, always focused on humanization and care, promoting multiprofessional assistance based on a welcoming dialogue, active listening and safe technical support.

Fundamento: Pessoas com transtornos mentais têm menor probabilidade de terem sua DCV e sua hipertensão diagnosticadas e possuem taxas de mortalidade duas ou três vezes maiores que a população em geral. Objetivos: estimar a prevalência de hipertensão através da autorreferência, do uso de medicamentos anti-hipertensivos e de valores de pressão arterial maiores ou iguais a 140 e 90 mmHg em população atendida em um Centro de Atenção Psicossocial na cidade de Salvador. Métodos: estudo transversal e exploratório realizado de agosto de 2019 a fevereiro de 2020, por meio da aplicação de questionário com informações sociodemográficas, avaliação clínica e anamnese. Resultados: foram avaliados 284 pacientes, 45,4% deles homens e a média de idade foi de 44,3 + 11,9 anos. A prevalência de hipertensão autorreferida e o uso de medicamentos anti-hipertensivos foram de 67 (23,6%) e 58 (20,4%), respectivamente. A frequência de valores pressóricos sistólico e diastólico acima de 140 x 90 mmHg foi de 47,8%. As frequências de obesidade e sobrepeso foram 40,8% e 31,6%, respectivamente. Foi encontrada prevalência de uso de pelo menos um antipsicótico de 254 (89,4%) e de polifarmácia de 103 (36,3%) pacientes. Conclusões: a prevalência de hipertensão arterial e o uso de medicamentos anti-hipertensivos em nossa população foi semelhante à população em geral. Também foram identificados fatores que podem aumentar o risco de desenvolver DCV, como a alta taxa de uso de medicamentos antipsicóticos e as prevalências de polifarmácia, obesidade e sobrepeso